Lv4
468 积分 2023-04-11 加入
The Efficacy and Safety of Amyloid Beta‐Directed Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta‐Analysis of Phase III Randomized Controlled Trials
2个月前
已完结
GLP-1 receptor agonist fails to halt Alzheimer’s disease
4个月前
已完结
Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current treatment strategy
4个月前
已完结
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial
5个月前
已完结
Here’s why China’s science and innovation model is thriving
8个月前
已完结
Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's disease
8个月前
已完结
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
9个月前
已完结
Impact of Pre-analytical Factors on Fluid Biomarker Measurements in Alzheimer Disease
9个月前
已完结
The genetic architecture of Parkinson's disease
9个月前
已完结
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
9个月前
已完结
皖公网安备34019202002308
